Related Experiment Videos
Mehri Salari1, Masoud Etemadifar2, Alireza Zali1,3
1Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Neurologia
|August 9, 2021
Summary
Parkinson's Disease (PD) patients experienced lower Covid-19 prevalence and mortality, possibly due to strict preventive measures. While Covid-19 did not significantly worsen motor symptoms, its impact on psychological status warrants further investigation.
Area of Science:
- Neurology
- Infectious Diseases
Context:
- The Covid-19 pandemic has disproportionately affected individuals with chronic health conditions.
- Parkinson's Disease (PD) patients, a vulnerable group, may experience exacerbated motor and neuropsychiatric symptoms due to Covid-19.
Purpose:
- To evaluate the impact of Covid-19 on Parkinson's Disease patients.
- To assess Covid-19 prevalence, mortality, and effects on motor and psychological symptoms in PD patients.
Summary:
- A study involving 647 PD patients found an 11.28% Covid-19 prevalence and 1.23% mortality.
- PD patients with prior contact with infected individuals showed a higher prevalence.
- No significant association was found between Covid-19 and worsening motor symptoms, though psychological effects were noted.
Impact:
- Findings suggest PD patients may adhere to stricter preventive protocols, potentially reducing Covid-19's impact.
- Further research is recommended to fully understand Covid-19's effects on PD motor and psychological symptoms.